Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
page
post
product
Home / News / altona Diagnostics launches research triplex PCR solution for chikungunya, dengue, and Zika viruses

altona Diagnostics launches research triplex PCR solution for chikungunya, dengue, and Zika viruses

We are pleased to announce the launch of the RealStar® CHIKV & DENV & ZIKV RT-PCR Kit 1.0 (RUO) designed for the qualitative detection and differentiation of chikungunya virus, dengue virus, and Zika virus.

 

Part of our fever, tropical, emerging (FTE) panel, our new assay is designed to deliver robust performance and reproducibility within research laboratory workflows. The kit supports efficient detection and clear differentiation of these three viruses in a single assay format.

 

Accurate differentiation enables researchers to generate high-quality datasets for surveillance studies, viral evolution analysis, vector competence research, and co-circulation modeling. It also supports studies aimed at understanding cross-reactivity, co-infection dynamics, and the impact of prior exposure on immune response. Reliable molecular tools are therefore critical for ensuring data integrity and comparability across studies and regions.

 

About the pathogen in general

Chikungunya, dengue, and Zika viruses are widely distributed across tropical and subtropical regions, including Asia, Africa, the Americas, and island regions of the Pacific and Caribbean. Their global footprint continues to expand as climate change, urbanization, and increased human mobility create favorable conditions for the spread of Aedes mosquito vectors, primarily Aedes aegypti and Aedes albopictus. These shared vectors and overlapping geographic ranges frequently result in co-infections and simultaneous outbreaks, presenting ongoing challenges for epidemiological research.

 

From a research perspective, differentiating between these viruses is essential due to their distinct virological characteristics and downstream impacts. While they often produce similar early symptoms in infected individuals, their biological behavior, immune responses, and long-term outcomes differ significantly.

 

Dengue virus is associated with a complex immune response and antibody-dependent enhancement, making it a key focus in pathogenesis and vaccine research. Chikungunya virus is widely studied for its ability to cause persistent joint inflammation and chronic disease, providing insights into viral-induced inflammatory mechanisms. Zika virus has drawn intense research attention due to its neurotropism and its association with congenital and neurological complications.

 

Find out more about our RealStar® CHIKV & DENV & ZIKV RT-PCR Kit 1.0 (RUO)